Pharma Mar reported EUR0.09 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.28 -0.23 May/29
FY2025Q4 Dec/2025 3.34 0.99 0.99 Mar/02
FY2025Q3 Sep/2025 -0.23 0.28 0.22 Oct/30
FY2025Q2 Jun/2025 1.32 0.01 0.07 Jul/30
FY2025Q1 Mar/2025 -0.23 -0.06 0.13 Apr/28




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Moderna USD -3.4 1.29 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Pharma Mar EUR 0.09 3.25 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026